ORGANON & CO (OGN) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:OGN • US68622V1061
8.42 USD
+0.42 (+5.25%)
Last: Feb 4, 2026, 10:41 AM
ChartMill assigns a Buy % Consensus number of 49% to OGN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.54. This target is 13.35% above the current price.
- OGN was analyzed by 16 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about OGN.
- In the previous month the buy percentage consensus was at a similar level.
- OGN was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-09 | Barclays | Initiate | Underweight |
| 2025-11-11 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-06 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-05-06 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-04-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-20 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-03 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-10-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-21 | Barclays | Initiate | Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-16 | Raymond James | Initiate | Outperform |
| 2022-11-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-06 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2022-08-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-07-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-27 | Goldman Sachs | Initiate | Buy |
| 2022-02-22 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-07 | Piper Sandler | Initiate | Neutral |
ORGANON & CO / OGN FAQ
Can you provide the average price target for ORGANON & CO stock?
16 analysts have analysed OGN and the average price target is 9.54 USD. This implies a price increase of 13.35% is expected in the next year compared to the current price of 8.42.
What is the consensus rating for ORGANON & CO (OGN) stock?
The consensus rating for ORGANON & CO (OGN) is 48.75 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for OGN stock?
The number of analysts covering ORGANON & CO (OGN) is 16.